<DOC>
	<DOCNO>NCT02078427</DOCNO>
	<brief_summary>The purpose study document natural history hemophilia . A disease long-term outcome term effectiveness , safety quality life ( QoL ) participant receive ADVATE routine clinical practice . Participants may use treatment regimen , include on-demand prophylaxis use standardized regimen individual pharmacokinetic ( PK ) -guided dose regimen , immune tolerance induction ( ITI ) therapy , determine treat physician .</brief_summary>
	<brief_title>ADVATE Hemophilia A Outcome Database ( AHEAD )</brief_title>
	<detailed_description />
	<mesh_term>Hemophilia A</mesh_term>
	<mesh_term>Factor VIII</mesh_term>
	<criteria>Participant hemophilia A ( Factor VIII ( FVIII ) â‰¤5 % ) Participant prescribe ADVATE treat physician Participant participant 's legally authorized representative provide informed consent Participant know hypersensitivity active substance excipients Participant know allergic reaction mouse hamster proteins Participant participate another clinical study involve investigational product ( IP ) device within 30 day prior study enrollment schedule participate another clinical study involve another FVIII concentrate device course study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>